Sanofi FY 2012 - Interview with CEO Chris Viehbacher Business Wire PARIS -- February 7, 2013 Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO Chris Viehbacher comments on 2012 results and outlook for 2013. Click to watch the video: http://bit.ly/XkZjhU Topics covered in the interview include: - 2012 Results - Genzyme - Emerging Markets - Diabetes franchise - R&D Pipeline - Animal Health - Capital Allocation - Cost savings - 2013 Guidance About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Company website: www.sanofi.com Contact: Sanofi Investor Relations: Sébastien Martel, +33 1 53 77 45 45 IR@sanofi.com or Media Relations: +33 1 53 77 45 02 MR@sanofi.com
Sanofi FY 2012 - Interview with CEO Chris Viehbacher
Press spacebar to pause and continue. Press esc to stop.